MedPath

Evaluation of guidelines for open access flexible sigmoidoscopy

Completed
Conditions
Colorectal cancer
Cancer
Malignant neoplasm of other and ill-defined digestive organs
Registration Number
ISRCTN53354739
Lead Sponsor
Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
0
Inclusion Criteria

1. Patients referred for open access flexible sigmoidoscopy and their referring practices.
2. Patients with symptomatic rectal bleeding referred for outpatient assessment prior to and during the study period.
3. < 18 years old

Exclusion Criteria

Does not match inclusion criteria

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Referrals/1000 population<br>2. Endoscopy findings<br>3. Final diagnoses<br>4. Time to diagnosis<br>5. Resource costs in primary and secondary care<br>6. Patient resource costs. <br>The introduction of the guideline had no significant effect on the selection of patients for investigation, but did influence patient management, both at the time of endoscopy and thereafter, the sum effect of which was reduced use of secondary care resources. GPs are selective in their use of an OAFS service for patients with rectal bleeding. The introduction of OAFS is cost effective and results in changes in case mix in referrals to specialist clinics. Non-malignant neoplasms were found more often in OAFS referrals, confirming the value of this service in evaluating low risk rectal bleeding.
Secondary Outcome Measures
NameTimeMethod
ot provided at time of registration
© Copyright 2025. All Rights Reserved by MedPath